You are here

  • Home
  • Archive
  • Volume 9, Issue Suppl 2
  • 484 Preliminary efficacy of the IL-15 superagonist SO-C101 in combination with pembrolizumab in patients with advanced/metastatic solid tumors

Article metrics

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Clinical Trials In Progress
484 Preliminary efficacy of the IL-15 superagonist SO-C101 in combination with pembrolizumab in patients with advanced/metastatic solid tumors

 

Online download statistics by month:

Online download statistics by month: November 2021 to November 2024

AbstractFullPdf
Nov 2021356022
Dec 202110603
Jan 20226404
Feb 20225807
Mar 202219607
Apr 20229809
May 202244013
Jun 20221206
Jul 20223202
Aug 20222201
Sep 202242010
Oct 20223808
Nov 202230010
Dec 20223803
Jan 20232608
Feb 20235807
Mar 20235401
Apr 20234201
May 20233203
Jun 20233806
Jul 20233408
Aug 20236406
Sep 20237405
Oct 20235005
Nov 20233002
Dec 20235404
Jan 20242601
Feb 20243403
Mar 202456013
Apr 202488011
May 20246809
Jun 20244806
Jul 20245607
Aug 20243004
Sep 202444012
Oct 20244809
Nov 20245007
Total22400243